Kactus Biosystems
PrivateLast Round
Series B
Oct 20, 2022
Est. Valuation
$21.3M
Total Funding Raised
$55.31M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Kactus Biosystems operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series B round in October 2022.
Kactus Biosystems is a biotechnology company that specializes in protein engineering and manufacturing, providing recombinant proteins, GMP-grade enzymes, and custom contract research services for drug discovery, immunotherapy, gene editing, and mRNA therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kactus Biosystems Comparables
Compare Kactus Biosystems with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BPS Bioscience | 85% | |
| ACROBiosystems | 82% | |
| ProSpec-Tany TechnoGene | 81% |
For institutional investors. Book with your work email.
Kactus Biosystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 20, 2022 | ||||
| Series A Extension | Jul 11, 2021 | ||||
| Series A | Sep 28, 2020 | ||||
| Pre Seed | Dec 20, 2018 | ||||
| Angel | Apr 26, 2018 | ||||
Angel | Mar 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Kactus Biosystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Alliance Capital | Series B |
| Lingang Blue Bay Capital | Series B |
| Shanghai Guofang Private Equity Fund Management | Series B |
| SDIC Venture Capital | Series A Extension, Series A |
| GF Capital Management & Advisors | Series B |
| Hudson Bay Capital Management | Series A Extension |
| Sherpa Healthcare Partners | Series A Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 68% MoM.
- May 22, 2026
Added Europabiosite, a biotechnology startup, as a customer.
For institutional investors. Book with your work email.
Kactus Biosystems Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kactus Biosystems's valuation, stock price, and market status.
Is Kactus Biosystems a public or private company?
Kactus Biosystems is a private company.
What is the current stock price of Kactus Biosystems?
Kactus Biosystems is a private company, so its shares have no public market price. Caplight tracks Kactus Biosystems's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kactus Biosystems worth (valuation)?
Kactus Biosystems's valuation is estimated at $21.3M based on funding round data.
Can I buy Kactus Biosystems stock?
Kactus Biosystems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kactus Biosystems's last funding round?
Kactus Biosystems's most recent funding round was Series B on October 20, 2022.
Who are the main investors in Kactus Biosystems?
Key investors in Kactus Biosystems include New Alliance Capital, SDIC Venture Capital, Hudson Bay Capital Management, Sherpa Healthcare Partners, Dehui Capital.
Will Kactus Biosystems IPO soon?
No public IPO plans have been announced for Kactus Biosystems.
How can I track Kactus Biosystems secondary market activity?
Caplight tracks bids, offers, and trades in Kactus Biosystems's shares on secondary markets.